Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
prenatal screening test
|
| gptkbp:accuracy |
high sensitivity and specificity for trisomy 21
|
| gptkbp:acquiredBy |
gptkb:Roche
|
| gptkbp:alternativeTo |
invasive prenatal diagnostic procedures
|
| gptkbp:analyzes |
cell-free fetal DNA
|
| gptkbp:detects |
gptkb:trisomy_21
chromosomal abnormalities trisomy 18 sex chromosome aneuploidies trisomy 13 |
| gptkbp:developedBy |
gptkb:Ariosa_Diagnostics
|
| gptkbp:FDAApproved |
no (as of 2024, laboratory-developed test)
|
| gptkbp:gestationalAge |
from 10 weeks
|
| https://www.w3.org/2000/01/rdf-schema#label |
Harmony Prenatal Test
|
| gptkbp:marketedIn |
gptkb:Asia
gptkb:Europe gptkb:United_States |
| gptkbp:method |
next-generation sequencing
|
| gptkbp:notDiagnostic |
true
|
| gptkbp:requiresFollowUp |
positive results should be confirmed by diagnostic testing
|
| gptkbp:turnaroundTime |
about 7 days
|
| gptkbp:type |
maternal blood
|
| gptkbp:usedFor |
non-invasive prenatal testing
|
| gptkbp:bfsParent |
gptkb:Aria_Diagnostics
|
| gptkbp:bfsLayer |
7
|